Literature DB >> 30682342

Induction of apoptosis by chalepin through phosphatidylserine externalisations and DNA fragmentation in breast cancer cells (MCF7).

Musa Isah Fakai1, Sri Nurestri Abd Malek2, Saiful Anuar Karsani3.   

Abstract

AIMS: Chalepin, a naturally occurring compound isolated from Ruta angustifolia have been shown to exert a promising anticancer activity through various mechanisms. Hence, the need to investigate the apoptotic inducing ability of chalepin in MCF7 cells by various detection assays.
MATERIALS AND METHODS: Cytotoxicity screening of chalepin against MCF7 cells was conducted using SRB assay. Apoptosis induction was examined by established morphological and biochemical assays including phase contrast and Hoechst/PI staining fluorescence microscope. Similarly, Annexin-V/FITC and TUNEL assays were conducted using flow cytometry whereas caspase-3 activity was evaluated using microplate reader. KEY
FINDINGS: The result indicates remarkable cytotoxic activity against MCF7 cells, whereas it shows moderate cytotoxic activity against MDA-MB231 cells. Interestingly, chalepin did not present any toxicity against MRC5 normal cell line. Morphological examination using both phase contrast and fluorescence microscope displays typical apoptotic features such as membrane blebbing, DNA fragmentation, chromatin condensation and apoptotic bodies' formation following chalepin treatment against MCF7 cells at different concentration for 48 h. Apoptosis induction is significantly associated with externalisation of phosphatidylserine, and DNA fragmentation in MCF7 cells chalepin treated cells when compared with control. The protein expressions of caspase-8, 9 and cleaved PARP1 were upregulated which correlated well with increased caspase-3 activity. SIGNIFICANCE: From our recent findings, chalepin was able to induced apoptosis in MCF7 cells and therefore, could be evaluated further as a potential source of anticancer agent for cancer treatment such as breast cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Chalepin; DNA fragmentation; MCF7 cells; Ruta angustifolia

Mesh:

Substances:

Year:  2019        PMID: 30682342     DOI: 10.1016/j.lfs.2019.01.029

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  Artemisinin-Type Drugs in Tumor Cell Death: Mechanisms, Combination Treatment with Biologics and Nanoparticle Delivery.

Authors:  Xinyu Zhou; Fengzhi Suo; Kristina Haslinger; Wim J Quax
Journal:  Pharmaceutics       Date:  2022-02-10       Impact factor: 6.321

2.  Effect of Silkworm Pupa Protein Hydrolysates on Proliferation of Gastric Cancer Cells In Vitro.

Authors:  Weixin Li; Lixia Mu; Yuxiao Zou; Weifei Wang; Haifeng Zhao; Xuli Wu; Sentai Liao
Journal:  Foods       Date:  2022-08-07

3.  Synthesis and Evaluation of the Antitumor Activity of Novel 1-(4-Substituted phenyl)-2-ethyl Imidazole Apoptosis Inducers In Vitro.

Authors:  Zhen-Wang Li; Chun-Yan Zhong; Xiao-Ran Wang; Shi-Nian Li; Chun-Yuan Pan; Xin Wang; Xian-Yu Sun
Journal:  Molecules       Date:  2020-09-18       Impact factor: 4.411

Review 4.  A narrative review of multiple mechanisms of progranulin in cancer: a potential target for anti-cancer therapy.

Authors:  Chenhui Zhou; Yi Huang; Jingmi Wu; Yiting Wei; Xiaosheng Chen; Zhiqing Lin; Sheng Nie
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

5.  Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer.

Authors:  Peramaiyan Rajendran; Rebai Ben Ammar; Fatma J Al-Saeedi; Maged Elsayed Mohamed; Mih Islam; Saeed Y Al-Ramadan
Journal:  J Cell Mol Med       Date:  2020-11-07       Impact factor: 5.295

6.  Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468.

Authors:  Maryam Ashourpour; Fatemeh Mostafavi Hosseini; Mohsen Amini; Ebrahim Saeedian Moghadam; Faranak Kazerouni; Seyed Yousef Arman; Zahra Shahsavari
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.